Zhaolin Xu

Drug repurposing for cancer therapy

Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours

Genistein and Procyanidin B2 Reduce Carcinogen-Induced Reactive Oxygen Species and DNA Damage through the Activation of Nrf2/ARE Cell Signaling in Bronchial Epithelial Cells In Vitro

Predicting EGFR mutation status in lung cancer:Proposal for a scoring model using imaging and demographic characteristics